On a global scale, lung cancer(LC) is the most commonly occurring form of cancer. Nonetheless, the process of screening and detecting it in its early stages presents significant challenges. Earlier research endeavors have recognized metabolites as potentially reliable biomarkers for LC. However, the majority of these studies have been limited in scope, featuring inconsistencies in terms of the relationships and levels of association observed.Moreover, there has been a lack of consistency in the types of biological samples utilized in previous studies. Therefore, the main objective of our research was to explore the correlation between metabolites and Non-small cell lung cancer (NSCLC).Thorough two-sample Mendelian randomization (TSMR) analysis, we investigated potential cause-and-effect relationships between 1400 metabolites and the risk of NSCLC.The analysis of TSMR revealed a significant causal impact of 61 metabolites on NSCLC.To ensure the reliability and validity of our findings, we perform FDR correction for P-values by Benjaminiand Hochberg(BH) method, Our results indicate that Oleate/vaccenate (18:1) levels and Caffeine to paraxanthine ratio may be causally associated with an increased risk of NSCLC [Oleate/vaccenate(18:1)levels: OR = 1.171,95%CI: 1.085–1.265, FDR = 0.036; Caffeine to paraxanthine ratio: OR = 1.386, 95%CI:1.191–1.612,FDR = 0.032].
Pulmonary arterial hypertension (PAH) is a rapidly progressing cardiopulmonary disease. It is characterized by increased pulmonary artery pressure and vascular resistance. The most notable histopathological characteristic is vascular remodeling. The changes in the basement membrane (BM) are believed to be related to vascular remodeling. It is crucial to identify potential biomarkers associated with the BM in PAH, to guide its treatment. The microarray datasets GSE117261 and GSE113439 were downloaded from the Gene Expression Omnibus. Two data sets were examined to identify genes associated with the BM by analyzing gene expression changes. Next, we analyzed the relevant genes in the Kyoto Encyclopedia of Genes and Genomes using Gene Ontology and Disease Ontology annotationand conducted pathway enrichment analysis. We conducted a protein–protein interaction network analysis on the genes related to BMs and used the cell cytoHubba plug-in to identify the hub genes. Furthermore, we conducted an immune infiltration analysis and implemented a histogram model. Finally, we predicted and analyzed potential therapeutic drugs for PAH and set up a miRNA network of genetic markers. Six candidate genes related to BMs, namely Integrin Subunit Alpha V, Integrin Subunit Alpha 4, ITGA2, ITGA9, Thrombospondin 1, and Collagen Type IV Alpha 3 Chain, were identified as potential modulators of the immune process in PAH. Furthermore, ginsenoside Rh1 was found to significantly impact drug targeting based on its interactions with the six BM-related genes identified earlier. A novel biomarker related to the BM, which plays a crucial role in the development of PAH, has been identified.
Esophageal cancer (EC) remains a major global health burden, and emerging research highlights the potential influence of the gut microbiome on its pathogenesis. However, the causal relationship between specific microbial taxa and EC, as well as the immunological mechanisms mediating these effects, remains unclear. A 2-sample Mendelian randomization analysis was performed using data from 619 EC cases and 314,193 controls in the FinnGen R10 cohort, together with genome-wide association summary statistics of 412 gut microbiota taxa and 731 immune phenotypes obtained from the National Human Genome Research Institute–European Bioinformatics Institute Genome-Wide Association Studies Catalog. The analysis aimed to determine causal links between the gut microbiome and EC, and to explore immune cell-mediated pathways through mediation analysis. The results revealed a significant protective association between Streptococcus thermophilus and EC risk (odds ratio = 0.586, 95% confidence interval = 0.402–0.855, P = .006). Mediation analysis indicated that terminally differentiated CD4+ T cells partially mediated this relationship, accounting for approximately 6% of the total effect. This study identifies Streptococcus thermophilus as a potentially protective gut commensal that may reduce EC risk through immune modulation. The findings provide novel insights into microbiome–immune–cancer interactions and suggest possible preventive or therapeutic targets for EC.
N6-methyladenosine (m6A) RNA modification plays a critical role in cancer biology, yet its causal impact on lung squamous cell carcinoma (LSCC) remains poorly understood. To address this, we intersected 19 known m6A-related genes with cis-expression quantitative trait loci datasets and identified 12 genes with reliable expression quantitative trait loci data. These genes were then used as exposures in Mendelian randomization (MR) analyses, with LSCC as the outcome. Our MR analysis revealed that methyltransferase like 14 (METTL14) exerts a significant protective effect against LSCC development (odds ratio [OR] = 0.734, 95% confidence interval [CI] = 0.567–0.950, P = .019). Further MR analysis at the immune cell level identified CD19+ IgD− CD38dim as a potential mediator. Specifically, METTL14 was positively associated with increased CD19+ IgD− CD38dim (OR = 1.636, 95% CI = 1.306–2.050, P < .001), and higher CD19 expression was associated with a reduced risk of LSCC (OR = 0.858, 95% CI = 0.767–0.961, P = .008). Mediation analysis indicated CD19+ IgD− CD38dim accounted for ~24.3% of the total effect of METTL14 on LSCC risk. Altogether, these findings suggest that the m6A demethylase METTL14 plays a protective role in the pathogenesis of LSCC, potentially by upregulating CD19+ IgD− CD38dim. This study is the first to establish a causal link between an m6A demethylase and LSCC risk, highlighting a novel METTL14-CD19-LSCC regulatory axis. The results not only provide new mechanistic insights into LSCC pathogenesis but also suggest potential clinical implications, including the development of METTL14-related biomarkers and immune-based therapeutic strategies.
In this study, we aimed to investigate the relationship between immune cell responses and lung cancer (LC), which is responsible for a significant number of cancer-related deaths globally and poses a serious threat to human well-being. Numerous studies have suggested a potential connection between immune cell activity and LC; nevertheless, the exact causal role of immune cells in LCremains uncertain. To address this gap in knowledge, we conducted a thorough two-sample Mendelian randomization (MR) analysis to establish a causal link between immune cell signatures and LC.By analyzing genetic data that is accessible to the public, we investigated potential cause-and-effect relationships between 731 immune cell signatures and the risk of LC. We considered four different types of immune signatures, including median fluorescence intensities (MFI), relative cell (RC), absolute cell (AC), and morphological parameters (MP). To ensure the reliability and validity of our findings, we conducted thorough sensitivity analyses to assess the robustness, variability, and potential confounding effects of the results.The analysis of Two-sample Mendelian randomization (MR) revealed a significant causal impact of 31 immune cells on LC. Conversely, the results of Reverse MR indicated a significant causal association between LC and 3 immune cells. By employing genetic methods, our study has effectively illustrated the strong connection between immune cells and LC, offering valuable insights for future clinical investigations.